Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Not applicableStudy completedNCT00569166
What this trial is testing

Three Different Programs of Paced Breathing in Treating Hot Flashes in Women

Who this might be right for
Breast CancerFatigueHot Flashes+1 more
Mayo Clinic 105
Testing effectiveness (Phase 2)Looking for participantsNCT06561555
What this trial is testing

A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

Who this might be right for
Mammary or Extramammary Paget's Disease
Fudan University 36
Not applicableStudy completedNCT07842055
What this trial is testing

AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinoma

Who this might be right for
Early-stage Invasive Lobular Breast Carcinoma
Hellenic Cooperative Oncology Group 3,648
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499
What this trial is testing

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

Who this might be right for
Epithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more
Klus Pharma Inc. 1,410
Not applicableLooking for participantsNCT05964504
What this trial is testing

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Who this might be right for
Metastatic Breast CancerLobular Breast Carcinoma
University of California, San Francisco 150
Early research (Phase 1)Study completedNCT01391143
What this trial is testing

Safety Study of MGA271 in Refractory Cancer

Who this might be right for
Prostate CancerMelanomaRenal Cell Carcinoma+4 more
MacroGenics 179
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Early research (Phase 1)Ended earlyNCT02952989
What this trial is testing

A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellBreast Neoplasms+5 more
Seagen Inc. 47
Not applicableUnknownNCT02617082
What this trial is testing

Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery

Who this might be right for
Breast Cancer
Fudan University 828
Testing effectiveness (Phase 2)Study completedNCT00416403
What this trial is testing

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 35
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Not applicableUnknownNCT00470236
What this trial is testing

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

Who this might be right for
Carcinoma, Ductal, Breast
Trans Tasman Radiation Oncology Group 1,608
Not applicableLooking for participantsNCT04985032
What this trial is testing

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Ductal Carcinoma in SituInvasive Ductal Carcinoma of Female Breast
RPCR, Inc. 200
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Not applicableStudy completedNCT01614002
What this trial is testing

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 371
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Next Page